Our Perspective

  • Measuring Mortality Risk for Hodgkin’s Lymphoma

    By Mary Murphy|October 10, 2013|English

    Hodgkin’s lymphoma (HL), formerly called Hodgkin’s disease, is a B-cell lymphoma that’s classified by the World Health Organization into one of five subtypes. The most common is nodular sclerosing, which accounts for 65% of HL in...

    Read More
  • Asking the Right Questions To Uncover High Risk Drinking

    By Ross Campbell |September 25, 2013|English

    Hazardous alcohol consumption is a big problem in many countries around the world - and in some places it is getting worse. The increase in under-age excess and “binge-drinking,” and the high-frequency consumption patterns of older people...

    Read More
  • Gen Re Research - New Zealand Mortality Investigation

    By Sara Goldberg |September 04, 2013|English

    Gen Re's Life/Health Research and Development has recently completed a mortality investigation of New Zealand assured lives in conjunction with the New Zealand Society of Actuaries and our Life colleagues in Australia. The report covers years 2008 –...

    Read More
  • Thoughts on Life/Health Insurance - After the Boomers

    By Drew King|August 02, 2013|English

    Fifteen years ago I heard a professional demographer speak at a conference. It was the first time I’d ever heard about or seen “bubble charts,” and I was fascinated by the way he predicted things that would happen in the future based...

    Read More
  • Critical Illness Compliance Issues

    By Steve Rowley |July 23, 2013|English

    Working through the filing process and addressing various state objections can be a daunting and frustrating task for nearly any insurance product. In the case of Critical Illness (CI) insurance, this task is compounded in many states by their inexperience...

    Read More
  • Big Wins From Big Data

    By Karin Neelsen |July 08, 2013|English

    Gen Re began collecting portfolio data from German life insurance companies around 20 years ago with a view to obtaining detailed insights into the market’s claims experience around mortality and disability products. For the insurers that contributed...

    Read More